Position changes including Representative Director and Executive Vice President, Managing Executive Director, Executive Officers, and Department Managers effective April 1, 2026.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"4694","jir_company_name":"BML, Inc.","jir_importance":"\u2605\u2605\u2605\u2606\u2606","jir_publication_date":"2026-03-30","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/03\/4694-20260330-01.pdf","jir_short_summary":"Position changes including Representative Director and Executive Vice President, Managing Executive Director, Executive Officers, and Department Managers effective April 1, 2026.","jir_summary":"### Overview of Personnel Changes\nBML, Inc. executed personnel changes for directors, executive officers, and department managers effective April 1, 2026. Among directors, Mr. Nobutaka Arai assumed multiple concurrent positions including Representative Director and Executive Vice President in charge of the BML Inspection Headquarters, as well as Head of the Genomic Medical Business Division, Chief of the Genomic QA Office, and Director of the BML Research Institute. Mr. Kenji Shibata\u2019s concurrent positions were also revised. Executive Officer Mr. Kazuhiro Yamashita was promoted to be in charge of the Electronic Medical Record Systems Department, and several managerial position changes were made at the department manager level.\n\n### Impact on Investors\nThese personnel changes aim to strengthen the management structure and improve organizational efficiency, notably changing leaders in the genomic medical business and electronic medical record systems divisions. This is expected to clarify leadership for future business development, though immediate direct impact on financial results is unclear.","jir_financial_highlights":"Effective Date: 2026\u5e744\u67081\u65e5 (Unknown)","jir_category":"","jir_hashtags":"#BMLInc, #PersonnelChanges, #JapaneseStocks","jir_key_figures":"Effective Date: 2026\u5e744\u67081\u65e5\nNew Roles of Representative Director and Executive Vice President Nobutaka Arai: Representative Director and Executive Vice President, Head of BML Inspection Headquarters, Head of Genomic Medical Business Division, Chief of Genomic QA Office, Director of BML Research Institute\nNew Role of Executive Officer Kazuhiro Yamashita: Executive Officer in charge of Electronic Medical Record Systems Department","jir_meta_title":"BML, Inc. Announces Personnel Changes Effective April 1, 2026","jir_meta_description":"BML, Inc. has announced personnel changes effective April 1, 2026, including Representative Director and Executive Vice President, directors, executive officers, and department managers, detailing changes aimed at strengthening the management structure.","jir_og_title":"BML, Inc. Notice of Personnel Changes (Effective April 1, 2026)","jir_og_description":"Position changes including Representative Director and Executive Vice President effective April 1, 2026. Details disclosed on personnel changes aimed at strengthening the organizational structure.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[]","ir_related_company":9186,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"executive_change","footnotes":""},"sector":[],"importance":[],"class_list":["post-37623","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n